Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
•
Gastric Cancer
•
Esophageal Cancer
Should I use PET/CT for GE junction treatment planning?
We use PET for esophageal, but not gastric cancer. GE junction seems like a grey area.
Answer from: Radiation Oncologist at Academic Institution
I consistently find PET scans very helpful for defining the extent of disease in GE junction tumors.
Sign in or Register to read more
321
Related Questions
How would you alter your treatment volumes in a patient with distal esophageal cancer who has had prior gastric bypass surgery?
Would you consider dose or margin alterations when treating a multifocal squamous cell carcinoma of the lower esophagus/GEJ and stomach in the neoadjuvant setting?
What dose constraints and how much CTV do you extend into stomach for a patient with a GEJ tumor being treated with pre-operative or definitive chemo-RT?
For an otherwise resectable esophageal cancer with involved celiac lymph nodes, would you ever consider an SIB beyond 50.4 Gy?
How would you approach treating a patient who refuses surgery, but has significant residual disease after chemoradiotherapy for squamous cell carcinoma of the esophagus?
Does an esophageal stent impact your radiation treatment plan for a patient with non-metastatic GE junction adenocarcinoma?
For a patient who has T4 squamous cell esophageal carcinoma on imaging, and who has biopsy-confirmed disease in an involved local lymph node, are EUS or EGD still indicated to complete workup?
For a patient with history of sleeve gastrectomy, now diagnosed with GE junction adenocarcinoma, would you alter standard radiation volumes or change your treatment strategy?
For esophageal adenocarcinoma with extensive associated Barrett's, would you extend your CTV coverage beyond the usual expansions to cover the areas of known Barrett's?
How would you treat a patient with a synchronous T1N2 non-small cell lung cancer and a T3N1 mid-rectal adenocarcinoma (MMR intact)?